Todd W Mayhood

Title: The Innovative Contributions of Todd W. Mayhood

Introduction

Todd W. Mayhood is a notable inventor based in Randolph, NJ (US), recognized for his significant contributions to the field of biotechnology. With a total of five patents to his name, he has made strides in the development of polypeptides that have potential applications in drug design and therapeutic interventions.

Latest Patents

Among his latest patents, one focuses on MEK1 polypeptides. This invention provides crystals of the MEK1 polypeptide, which are particularly useful for structure-based drug design, along with methods of use. Another significant patent involves the kinase domain polypeptide of human protein kinase B gamma (AKT3). This invention includes AKT3 polypeptides and methods for their use, particularly in screening for AKT3 inhibitors, along with nucleic acids encoding these polypeptides.

Career Highlights

Throughout his career, Todd has worked with prominent companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative work.

Collaborations

Todd has collaborated with notable individuals in his field, including Thierry Olivier Fischmann and Vincent Stewart Madison. These collaborations have likely enriched his research and development efforts.

Conclusion

Todd W. Mayhood's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug design and therapeutic applications.